Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Karla Mišura Jakubac"'
Autor:
Vibor Milunović, Martina Bogeljić Patekar, Karla Mišura Jakubac, Inga Mandac Rogulj, Delfa Radić-Krišto, Ana Planinc-Peraica, Slobodanka Ostojić Kolonić
Publikováno v:
Acta Clinica Croatica, Vol 56., Iss 1., Pp 143-156 (2017)
Rituximab is a chimeric monoclonal CD20 antibody used in the treatment of CD20 positive non-Hodgkin lymphomas and has revolutionized treatment approach to these hematologic malignancies in the last decade. The main aim of this review is to present da
Externí odkaz:
https://doaj.org/article/56a6185676fe49db91e004668b948a8e
Autor:
Ana Planinc-Peraica, Slobodanka Ostojić Kolonić, Inga Mandac Rogulj, Vibor Milunović, Karla Mišura Jakubac, Delfa Radić-Krišto, Martina Bogeljić Patekar
Publikováno v:
Acta Clinica Croatica, Vol 56., Iss 1., Pp 143-156 (2017)
Rituximab is a chimeric monoclonal CD20 antibody used in the treatment of CD20 positive non-Hodgkin lymphomas and has revolutionized treatment approach to these hematologic malignancies in the last decade. The main aim of this review is to present da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f944ea1807a37d155a3fff764d3a6311
https://pubmed.ncbi.nlm.nih.gov/29120553
https://pubmed.ncbi.nlm.nih.gov/29120553